Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Cu(II)ATSM in Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease
NCT04082832 is registered in ClinicalTrials.gov with Collaborative Medicinal Development Pty Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Cu(II)ATSM in Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease
- Lead sponsor
- Collaborative Medicinal Development Pty Limited
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- September 30, 2019
- Completion date
- December 30, 2020
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.